MiR-30a increases MDSC differentiation and immunosuppressive function by targeting SOCS3 in mice with B-cell lymphoma

Zhen Xu1, Jianjian Ji1, Jingjing Xu1

  • 1The State Key Laboratory of Pharmaceutical Biotechnology, Division of Immunology, Medical School, Nanjing University, Nanjing, China.

The FEBS Journal
|June 13, 2017
PubMed

Related Concept Videos